N-[1-[4-(4-methoxyphenyl)piperazin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-methyl-2-oxo-1,3-benzoxazole-6-sulfonamide

C25H32N4O6S — CID 20864208

IUPACN-[1-[4-(4-methoxyphenyl)piperazin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-methyl-2-oxo-1,3-benzoxazole-6-sulfonamide
SMILESCOc1ccc(N2CCN(C(=O)C(CC(C)C)NS(=O)(=O)c3ccc4c(c3)oc(=O)n4C)CC2)cc1
InChIInChI=1S/C25H32N4O6S/c1-17(2)15-21(26-36(32,33)20-9-10-22-23(16-20)35-25(31)27(22)3)24(30)29-13-11-28(12-14-29)18-5-7-19(34-4)8-6-18/h5-10,16-17,21,26H,11-15H2,1-4H3
InChIKeyWANILIRSKDQERH-UHFFFAOYSA-N
MW516.62 g/mol
LogP2.18
Rot. Bonds8

About N-[1-[4-(4-methoxyphenyl)piperazin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-methyl-2-oxo-1,3-benzoxazole-6-sulfonamide

N-[1-[4-(4-methoxyphenyl)piperazin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-methyl-2-oxo-1,3-benzoxazole-6-sulfonamide (PubChem CID 20864208) has the molecular formula C25H32N4O6S and a molecular weight of 516.62 g/mol. Its IUPAC name is N-[1-[4-(4-methoxyphenyl)piperazin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-methyl-2-oxo-1,3-benzoxazole-6-sulfonamide.

Molecular Properties

Compound NameN-[1-[4-(4-methoxyphenyl)piperazin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-methyl-2-oxo-1,3-benzoxazole-6-sulfonamide
PubChem CID20864208
Molecular FormulaC25H32N4O6S
Molecular Weight516.62 g/mol
Exact Mass516.20
IUPAC NameN-[1-[4-(4-methoxyphenyl)piperazin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-methyl-2-oxo-1,3-benzoxazole-6-sulfonamide
SMILESCOc1ccc(N2CCN(C(=O)C(CC(C)C)NS(=O)(=O)c3ccc4c(c3)oc(=O)n4C)CC2)cc1
InChIInChI=1S/C25H32N4O6S/c1-17(2)15-21(26-36(32,33)20-9-10-22-23(16-20)35-25(31)27(22)3)24(30)29-13-11-28(12-14-29)18-5-7-19(34-4)8-6-18/h5-10,16-17,21,26H,11-15H2,1-4H3
InChIKeyWANILIRSKDQERH-UHFFFAOYSA-N
XLogP2.18
TPSA114.09 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds8
Heavy Atoms36
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500516.62
LogP ≤ 52.18
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_C(246)', 'substructure': 'N/A'}

Analyze N-[1-[4-(4-methoxyphenyl)piperazin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-methyl-2-oxo-1,3-benzoxazole-6-sulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[1-[4-(4-methoxyphenyl)piperazin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-methyl-2-oxo-1,3-benzoxazole-6-sulfonamide?
The IUPAC name of N-[1-[4-(4-methoxyphenyl)piperazin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-methyl-2-oxo-1,3-benzoxazole-6-sulfonamide (CID 20864208) is N-[1-[4-(4-methoxyphenyl)piperazin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-methyl-2-oxo-1,3-benzoxazole-6-sulfonamide.
What is the SMILES notation for N-[1-[4-(4-methoxyphenyl)piperazin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-methyl-2-oxo-1,3-benzoxazole-6-sulfonamide?
The canonical SMILES for N-[1-[4-(4-methoxyphenyl)piperazin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-methyl-2-oxo-1,3-benzoxazole-6-sulfonamide is COc1ccc(N2CCN(C(=O)C(CC(C)C)NS(=O)(=O)c3ccc4c(c3)oc(=O)n4C)CC2)cc1.
What is the InChIKey of N-[1-[4-(4-methoxyphenyl)piperazin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-methyl-2-oxo-1,3-benzoxazole-6-sulfonamide?
The InChIKey is WANILIRSKDQERH-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H32N4O6S/c1-17(2)15-21(26-36(32,33)20-9-10-22-23(16-20)35-25(31)27(22)3)24(30)29-13-11-28(12-14-29)18-5-7-19(34-4)8-6-18/h5-10,16-17,21,26H,11-15H2,1-4H3.
What are the key properties of N-[1-[4-(4-methoxyphenyl)piperazin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-methyl-2-oxo-1,3-benzoxazole-6-sulfonamide?
N-[1-[4-(4-methoxyphenyl)piperazin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-methyl-2-oxo-1,3-benzoxazole-6-sulfonamide has a molecular weight of 516.62 g/mol, XLogP of 2.18, 8 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-[4-(4-methoxyphenyl)piperazin-1-yl]-4-methyl-1-oxopentan-2-yl]-3-methyl-2-oxo-1,3-benzoxazole-6-sulfonamide is sourced from PubChem (CID 20864208), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).